{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:50:27Z","timestamp":1785297027491,"version":"3.55.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA294365"],"award-info":[{"award-number":["CA294365"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR081487"],"award-info":[{"award-number":["AR081487"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rhabdomyosarcoma (RMS) is a pediatric soft-tissue sarcoma arising from mesenchymal progenitors with skeletal muscle features. The unfolded protein response (UPR) maintains proteostasis during endoplasmic reticulum stress, with the IRE1\u03b1-XBP1 axis representing a key signaling branch. Here, we demonstrate that components of this pathway are significantly upregulated in RMS cell lines and primary tumors. Genetic or pharmacological inhibition of IRE1\u03b1 or spliced XBP1 (sXBP1) suppresses cell proliferation, promotes terminal myogenic differentiation, and enhances vincristine-induced cytotoxicity in RMS cells. Silencing of sXBP1 further reduces the cancer stem-like cell population and impairs migration and invasion. Mechanistically, IRE1\u03b1-XBP1 signaling promotes RMS progression through sXBP1-dependent upregulation of BMPR1A and subsequent activation of BMP-SMAD1 signaling. Consistently, inducible knockdown of sXBP1 or pharmacological inhibition of IRE1\u03b1 endonuclease activity significantly attenuates xenograft RMS growth. Collectively, these findings identify the IRE1\u03b1-XBP1 axis as a critical regulator of RMS growth, differentiation, and\u00a0chemosensitivity, and support its therapeutic targeting in RMS.<\/jats:p>","DOI":"10.1038\/s42003-026-10184-1","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:50:25Z","timestamp":1778028625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting the IRE1\u03b1-XBP1 signaling axis impairs tumor growth and promotes myogenic differentiation in rhabdomyosarcoma"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5162-1953","authenticated-orcid":false,"given":"Anh Tuan","family":"Vuong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1595-5945","authenticated-orcid":false,"given":"Aniket S.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong T.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7479-2595","authenticated-orcid":false,"given":"Meiricris","family":"Tomaz da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghana V.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8571-2848","authenticated-orcid":false,"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"10184_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/pbc.24435","volume":"60","author":"DS Hawkins","year":"2013","unstructured":"Hawkins, D. S., Spunt, S. L., Skapek, S. X. & Committee, C. O. G. S. T. S. Children\u2019s Oncology Group\u2019s 2013 blueprint for research: Soft tissue sarcomas. Pediatr. Blood Cancer 60, 1001\u20131008 (2013).","journal-title":"Pediatr. Blood Cancer"},{"key":"10184_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3961","volume":"15","author":"VP Kashi","year":"2015","unstructured":"Kashi, V. P., Hatley, M. E. & Galindo, R. L. Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems. Nat. Rev. Cancer 15, 426\u2013439 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"10184_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-139","volume":"14","author":"R Ciarapica","year":"2014","unstructured":"Ciarapica, R. et al. Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS. BMC Cancer 14, 139 (2014).","journal-title":"BMC Cancer"},{"key":"10184_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/pbc.24118","volume":"59","author":"S Malempati","year":"2012","unstructured":"Malempati, S. & Hawkins, D. S. Rhabdomyosarcoma: review of the Children\u2019s Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies. Pediatr. Blood Cancer 59, 5\u201310 (2012).","journal-title":"Pediatr. Blood Cancer"},{"key":"10184_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4161\/cbt.51","volume":"1","author":"SJ Xia","year":"2002","unstructured":"Xia, S. J., Pressey, J. G. & Barr, F. G. Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol. Ther. 1, 97\u2013104 (2002).","journal-title":"Cancer Biol. Ther."},{"key":"10184_CR6","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1111\/febs.12421","volume":"280","author":"C Keller","year":"2013","unstructured":"Keller, C. & Guttridge, D. C. Mechanisms of impaired differentiation in rhabdomyosarcoma. FEBS J. 280, 4323\u20134334 (2013).","journal-title":"FEBS J."},{"key":"10184_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101124","volume":"25","author":"A Pal","year":"2019","unstructured":"Pal, A., Chiu, H. Y. & Taneja, R. Genetics, epigenetics and redox homeostasis in rhabdomyosarcoma: Emerging targets and therapeutics. Redox Biol. 25, 101124 (2019).","journal-title":"Redox Biol."},{"key":"10184_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn4180","volume":"381","author":"X Lv","year":"2023","unstructured":"Lv, X. et al. Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors. Science 381, eabn4180 (2023).","journal-title":"Science"},{"key":"10184_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrc3800","volume":"14","author":"M Wang","year":"2014","unstructured":"Wang, M. & Kaufman, R. J. The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat. Rev. Cancer 14, 581\u2013597 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"10184_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1158\/2159-8290.CD-14-1490","volume":"5","author":"E Chevet","year":"2015","unstructured":"Chevet, E., Hetz, C. & Samali, A. Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis. Cancer Discov. 5, 586\u2013597 (2015).","journal-title":"Cancer Discov."},{"key":"10184_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/sj.cdd.4401840","volume":"13","author":"J Wu","year":"2006","unstructured":"Wu, J. & Kaufman, R. J. From acute ER stress to physiological roles of the unfolded protein response. Cell Death Differ. 13, 374\u2013384 (2006).","journal-title":"Cell Death Differ."},{"key":"10184_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrm3270","volume":"13","author":"C Hetz","year":"2012","unstructured":"Hetz, C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 13, 89\u2013102 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10184_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107169","volume":"300","author":"S Le Goupil","year":"2024","unstructured":"Le Goupil, S., Laprade, H., Aubry, M. & Chevet, E. Exploring the IRE1 interactome: from canonical signaling functions to unexpected roles. J. Biol. Chem. 300, 107169 (2024).","journal-title":"J. Biol. Chem."},{"key":"10184_CR14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3390\/biomedicines9070791","volume":"9","author":"SM Park","year":"2021","unstructured":"Park, S. M., Kang, T. I. & So, J. S. Roles of XBP1s in transcriptional regulation of target genes. Biomedicines 9, 791 (2021).","journal-title":"Biomedicines"},{"key":"10184_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2014.02.008","volume":"39","author":"M Maurel","year":"2014","unstructured":"Maurel, M., Chevet, E., Tavernier, J. & Gerlo, S. Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem. Sci. 39, 245\u2013254 (2014).","journal-title":"Trends Biochem. Sci."},{"key":"10184_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1083\/jcb.200903014","volume":"186","author":"J Hollien","year":"2009","unstructured":"Hollien, J. et al. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J. Cell Biol. 186, 323\u2013331 (2009).","journal-title":"J. Cell Biol."},{"key":"10184_CR17","doi-asserted-by":"publisher","first-page":"16420","DOI":"10.1073\/pnas.1906999116","volume":"116","author":"JM Harnoss","year":"2019","unstructured":"Harnoss, J. M. et al. Disruption of IRE1alpha through its kinase domain attenuates multiple myeloma. Proc. Natl. Acad. Sci. USA 116, 16420\u201316429 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10184_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ccr.2007.02.015","volume":"11","author":"DR Carrasco","year":"2007","unstructured":"Carrasco, D. R. et al. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis. Cancer Cell 11, 349\u2013360 (2007).","journal-title":"Cancer Cell"},{"key":"10184_CR19","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1172\/JCI73448","volume":"124","author":"CH Tang","year":"2014","unstructured":"Tang, C. H. et al. Inhibition of ER stress-associated IRE-1\/XBP-1 pathway reduces leukemic cell survival. J. Clin. Invest. 124, 2585\u20132598 (2014).","journal-title":"J. Clin. Invest."},{"key":"10184_CR20","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1158\/0008-5472.CAN-19-3108","volume":"80","author":"JM Harnoss","year":"2020","unstructured":"Harnoss, J. M. et al. IRE1alpha disruption in triple-negative breast cancer cooperates with antiangiogenic therapy by reversing ER stress adaptation and remodeling the tumor microenvironment. Cancer Res. 80, 2368\u20132379 (2020).","journal-title":"Cancer Res."},{"key":"10184_CR21","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1172\/JCI95873","volume":"128","author":"N Zhao","year":"2018","unstructured":"Zhao, N. et al. Pharmacological targeting of MYC-regulated IRE1\/XBP1 pathway suppresses MYC-driven breast cancer. J. Clin. Invest. 128, 1283\u20131299 (2018).","journal-title":"J. Clin. Invest."},{"key":"10184_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature13119","volume":"508","author":"X Chen","year":"2014","unstructured":"Chen, X. et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway. Nature 508, 103\u2013107 (2014).","journal-title":"Nature"},{"key":"10184_CR23","doi-asserted-by":"publisher","first-page":"6738","DOI":"10.1038\/onc.2017.284","volume":"36","author":"XX Li","year":"2017","unstructured":"Li, X. X. et al. Knockdown of IRE1alpha inhibits colonic tumorigenesis through decreasing beta-catenin and IRE1alpha targeting suppresses colon cancer cells. Oncogene 36, 6738\u20136746 (2017).","journal-title":"Oncogene"},{"key":"10184_CR24","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1084\/jem.20122341","volume":"210","author":"L Niederreiter","year":"2013","unstructured":"Niederreiter, L. et al. ER stress transcription factor Xbp1 suppresses intestinal tumorigenesis and directs intestinal stem cells. J. Exp. Med. 210, 2041\u20132056 (2013).","journal-title":"J. Exp. Med."},{"key":"10184_CR25","doi-asserted-by":"publisher","first-page":"e3003086","DOI":"10.1371\/journal.pbio.3003086","volume":"23","author":"I Zuazo-Gaztelu","year":"2025","unstructured":"Zuazo-Gaztelu, I. et al. A nonenzymatic dependency on inositol-requiring enzyme 1 controls cancer cell cycle progression and tumor growth. PLoS Biol. 23, e3003086 (2025).","journal-title":"PLoS Biol."},{"key":"10184_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143737","volume":"131","author":"S He","year":"2021","unstructured":"He, S. et al. IRE1\u03b1 regulates skeletal muscle regeneration through myostatin mRNA decay.  J. Clin. Invest. 131, e143737 (2021).","journal-title":"J. Clin. Invest."},{"key":"10184_CR27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73215","volume":"10","author":"A Roy","year":"2021","unstructured":"Roy, A. et al. The IRE1\/XBP1 signaling axis promotes skeletal muscle regeneration through a cell non-autonomous mechanism. eLife 10, e73215 (2021).","journal-title":"eLife"},{"key":"10184_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111372","volume":"27","author":"AS Joshi","year":"2024","unstructured":"Joshi, A. S. et al. Single-nucleus transcriptomic analysis reveals the regulatory circuitry of myofiber XBP1 during regenerative myogenesis. iScience 27, 111372 (2024).","journal-title":"iScience"},{"key":"10184_CR29","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1038\/s44319-024-00197-4","volume":"25","author":"AS Joshi","year":"2024","unstructured":"Joshi, A. S. et al. The IRE1alpha\/XBP1 signaling axis drives myoblast fusion in adult skeletal muscle. EMBO Rep. 25, 3627\u20133650 (2024).","journal-title":"EMBO Rep."},{"key":"10184_CR30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41589-019-0326-2","volume":"15","author":"C Hetz","year":"2019","unstructured":"Hetz, C., Axten, J. M. & Patterson, J. B. Pharmacological targeting of the unfolded protein response for disease intervention. Nat. Chem. Biol. 15, 764\u2013775 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"10184_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167378","volume":"434","author":"N Ketelut-Carneiro","year":"2022","unstructured":"Ketelut-Carneiro, N. & Fitzgerald, K. A. Apoptosis, pyroptosis, and necroptosis-oh my! the many ways a cell can die. J. Mol. Biol. 434, 167378 (2022).","journal-title":"J. Mol. Biol."},{"key":"10184_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.72","volume":"6","author":"T Avril","year":"2017","unstructured":"Avril, T., Vauleon, E. & Chevet, E. Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers. Oncogenesis 6, e373 (2017).","journal-title":"Oncogenesis"},{"key":"10184_CR33","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/S1470-2045(19)30617-5","volume":"20","author":"G Bisogno","year":"2019","unstructured":"Bisogno, G. et al. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 20, 1566\u20131575 (2019).","journal-title":"Lancet Oncol."},{"key":"10184_CR34","doi-asserted-by":"publisher","unstructured":"Miwa, S. et al. Recent advances and challenges in the treatment of rhabdomyosarcoma. Cancers https:\/\/doi.org\/10.3390\/cancers12071758 (2020).","DOI":"10.3390\/cancers12071758"},{"key":"10184_CR35","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983\u20133988 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10184_CR36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrd4253","volume":"13","author":"DR Pattabiraman","year":"2014","unstructured":"Pattabiraman, D. R. & Weinberg, R. A. Tackling the cancer stem cells - what challenges do they pose? Nat. Rev. Drug Discov. 13, 497\u2013512 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"10184_CR37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ncb2717","volume":"15","author":"JP Medema","year":"2013","unstructured":"Medema, J. P. Cancer stem cells: the challenges ahead. Nat. Cell Biol. 15, 338\u2013344 (2013).","journal-title":"Nat. Cell Biol."},{"key":"10184_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/ctm.ctm_69_16","volume":"3","author":"W Zhao","year":"2017","unstructured":"Zhao, W., Li, Y. & Zhang, X. Stemness-related markers in cancer. Cancer Transl. Med. 3, 87\u201395 (2017).","journal-title":"Cancer Transl. Med."},{"key":"10184_CR39","doi-asserted-by":"publisher","unstructured":"Generali, M. et al. High frequency of tumor propagating cells in fusion-positive rhabdomyosarcoma. Genes https:\/\/doi.org\/10.3390\/genes12091373 (2021).","DOI":"10.3390\/genes12091373"},{"key":"10184_CR40","doi-asserted-by":"publisher","unstructured":"Radzikowska, J. et al. Cancer stem cell markers in rhabdomyosarcoma in children. Diagnostics https:\/\/doi.org\/10.3390\/diagnostics12081895 (2022).","DOI":"10.3390\/diagnostics12081895"},{"key":"10184_CR41","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1158\/1541-7786.MCR-17-0004","volume":"15","author":"KK Slemmons","year":"2017","unstructured":"Slemmons, K. K. et al. A novel Notch-YAP circuit drives stemness and tumorigenesis in embryonal rhabdomyosarcoma. Mol. Cancer Res. 15, 1777\u20131791 (2017).","journal-title":"Mol. Cancer Res."},{"key":"10184_CR42","doi-asserted-by":"publisher","unstructured":"Slemmons, K. K. et al. A method to culture human alveolar rhabdomyosarcoma cell lines as rhabdospheres demonstrates an enrichment in stemness and Notch signaling. Biol. Open https:\/\/doi.org\/10.1242\/bio.050211 (2021).","DOI":"10.1242\/bio.050211"},{"key":"10184_CR43","doi-asserted-by":"publisher","first-page":"e19506","DOI":"10.1371\/journal.pone.0019506","volume":"6","author":"D Walter","year":"2011","unstructured":"Walter, D. et al. CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres. PLoS ONE 6, e19506 (2011).","journal-title":"PLoS ONE"},{"key":"10184_CR44","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/path.5848","volume":"256","author":"A Nachiyappan","year":"2022","unstructured":"Nachiyappan, A., Soon, J. L. J., Lim, H. J., Lee, V. K. & Taneja, R. EHMT1 promotes tumor progression and maintains stemness by regulating ALDH1A1 expression in alveolar rhabdomyosarcoma. J. Pathol. 256, 349\u2013362 (2022).","journal-title":"J. Pathol."},{"key":"10184_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omto.2017.10.002","volume":"8","author":"DH Bach","year":"2018","unstructured":"Bach, D. H., Park, H. J. & Lee, S. K. The dual role of bone morphogenetic proteins in cancer. Mol. Ther. Oncolytics 8, 1\u201313 (2018).","journal-title":"Mol. Ther. Oncolytics"},{"key":"10184_CR46","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1016\/j.bmcl.2008.06.052","volume":"18","author":"GD Cuny","year":"2008","unstructured":"Cuny, G. D. et al. Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg. Med. Chem. Lett. 18, 4388\u20134392 (2008).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10184_CR47","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1021\/acs.jmedchem.2c01886","volume":"66","author":"RK Modukuri","year":"2023","unstructured":"Modukuri, R. K. et al. Discovery of highly potent and BMPR2-selective kinase inhibitors using DNA-encoded chemical library screening. J. Med. Chem. 66, 2143\u20132160 (2023).","journal-title":"J. Med. Chem."},{"key":"10184_CR48","doi-asserted-by":"publisher","unstructured":"Skapek, S. X. et al. Rhabdomyosarcoma. Nat. Rev. Dis. Primers https:\/\/doi.org\/10.1038\/s41572-018-0051-2 (2019).","DOI":"10.1038\/s41572-018-0051-2"},{"key":"10184_CR49","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.trecan.2016.03.007","volume":"2","author":"H Urra","year":"2016","unstructured":"Urra, H., Dufey, E., Avril, T., Chevet, E. & Hetz, C. Endoplasmic reticulum stress and the hallmarks of cancer. Trends Cancer 2, 252\u2013262 (2016).","journal-title":"Trends Cancer"},{"key":"10184_CR50","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41420-024-02110-3","volume":"10","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. Endoplasmic reticulum stress-a key guardian in cancer. Cell Death Discov. 10, 343 (2024).","journal-title":"Cell Death Discov."},{"key":"10184_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08152-3","volume":"10","author":"X Sheng","year":"2019","unstructured":"Sheng, X. et al. IRE1alpha-XBP1s pathway promotes prostate cancer by activating c-MYC signaling. Nat. Commun. 10, 323 (2019).","journal-title":"Nat. Commun."},{"key":"10184_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2015.04.002","volume":"33","author":"F Tameire","year":"2015","unstructured":"Tameire, F., Verginadis, I. I. & Koumenis, C. Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: mechanisms and targets for therapy. Semin. Cancer Biol. 33, 3\u201315 (2015).","journal-title":"Semin. Cancer Biol."},{"key":"10184_CR53","doi-asserted-by":"publisher","unstructured":"Lhomond, S. et al. Dual IRE1 RNase functions dictate glioblastoma development. EMBO Mol. Med. https:\/\/doi.org\/10.15252\/emmm.201707929 (2018).","DOI":"10.15252\/emmm.201707929"},{"key":"10184_CR54","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.cell.2016.12.004","volume":"168","author":"JR Cubillos-Ruiz","year":"2017","unstructured":"Cubillos-Ruiz, J. R., Bettigole, S. E. & Glimcher, L. H. Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer. Cell 168, 692\u2013706 (2017).","journal-title":"Cell"},{"key":"10184_CR55","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canlet.2020.07.009","volume":"490","author":"N McCarthy","year":"2020","unstructured":"McCarthy, N. et al. The IRE1 and PERK arms of the unfolded protein response promote survival of rhabdomyosarcoma cells. Cancer Lett. 490, 76\u201388 (2020).","journal-title":"Cancer Lett."},{"key":"10184_CR56","doi-asserted-by":"publisher","unstructured":"Hsu, S. K. et al. Unfolded protein response (UPR) in survival, dormancy, immunosuppression, metastasis, and treatments of cancer cells. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20102518 (2019).","DOI":"10.3390\/ijms20102518"},{"key":"10184_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05763-8","volume":"9","author":"SE Logue","year":"2018","unstructured":"Logue, S. E. et al. Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nat. Commun. 9, 3267 (2018).","journal-title":"Nat. Commun."},{"key":"10184_CR58","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1111\/1759-7714.15442","volume":"15","author":"Y Xu","year":"2024","unstructured":"Xu, Y. et al. IRE1alpha-XBP1s axis regulates SREBP1-dependent MRP1 expression to promote chemoresistance in non-small cell lung cancer cells. Thorac. Cancer 15, 2116\u20132127 (2024).","journal-title":"Thorac. Cancer"},{"key":"10184_CR59","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","volume":"10","author":"H Lee","year":"2025","unstructured":"Lee, H. et al. Cancer stem cells: landscape, challenges and emerging therapeutic innovations. Signal Transduct. Target. Ther. 10, 248 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"10184_CR60","first-page":"2277","volume":"12","author":"Y Li","year":"2022","unstructured":"Li, Y., Lu, L., Zhang, G., Ji, G. & Xu, H. The role and therapeutic implication of endoplasmic reticulum stress in inflammatory cancer transformation. Am. J. Cancer Res. 12, 2277\u20132292 (2022).","journal-title":"Am. J. Cancer Res."},{"key":"10184_CR61","doi-asserted-by":"publisher","first-page":"a025650","DOI":"10.1101\/cshperspect.a025650","volume":"4","author":"S Hettmer","year":"2014","unstructured":"Hettmer, S. et al. Rhabdomyosarcoma: current challenges and their implications for developing therapies. Cold Spring Harb. Perspect. Med. 4, a025650 (2014).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10184_CR62","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/cdd.2010.95","volume":"18","author":"Y Ono","year":"2011","unstructured":"Ono, Y. et al. BMP signalling permits population expansion by preventing premature myogenic differentiation in muscle satellite cells. Cell Death Differ. 18, 222\u2013234 (2011).","journal-title":"Cell Death Differ."},{"key":"10184_CR63","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1083\/jcb.200511036","volume":"175","author":"NY Frank","year":"2006","unstructured":"Frank, N. Y. et al. Regulation of myogenic progenitor proliferation in human fetal skeletal muscle by BMP4 and its antagonist Gremlin. J. Cell Biol. 175, 99\u2013110 (2006).","journal-title":"J. Cell Biol."},{"key":"10184_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1042-7","volume":"9","author":"T Voeltzel","year":"2018","unstructured":"Voeltzel, T. et al. A new signaling cascade linking BMP4, BMPR1A, DeltaNp73 and NANOG impacts on stem-like human cell properties and patient outcome. Cell Death Dis. 9, 1011 (2018).","journal-title":"Cell Death Dis."},{"key":"10184_CR65","doi-asserted-by":"publisher","first-page":"22890","DOI":"10.18632\/oncotarget.4413","volume":"6","author":"MW Pickup","year":"2015","unstructured":"Pickup, M. W. et al. Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis. Oncotarget 6, 22890\u201322904 (2015).","journal-title":"Oncotarget"},{"key":"10184_CR66","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202408155","volume":"224","author":"A Chronopoulos","year":"2025","unstructured":"Chronopoulos, A. et al. The PAX3-FOXO1 fusion gene reduces cell-ECM interactions and TGFbeta signaling in rhabdomyosarcoma. J. Cell Biol. 224, e202408155 (2025).","journal-title":"J. Cell Biol."},{"key":"10184_CR67","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/j.1349-7006.2010.01512.x","volume":"101","author":"S Wang","year":"2010","unstructured":"Wang, S. et al. TGF-beta1 signal pathway may contribute to rhabdomyosarcoma development by inhibiting differentiation. Cancer Sci. 101, 1108\u20131116 (2010).","journal-title":"Cancer Sci."},{"key":"10184_CR68","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/gcc.20489","volume":"46","author":"M Goldstein","year":"2007","unstructured":"Goldstein, M., Meller, I. & Orr-Urtreger, A. FGFR1 over-expression in primary rhabdomyosarcoma tumors is associated with hypomethylation of a 5\u2019 CpG island and abnormal expression of the AKT1, NOG, and BMP4 genes. Genes Chromosomes Cancer 46, 1028\u20131038 (2007).","journal-title":"Genes Chromosomes Cancer"},{"key":"10184_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"10184_CR70","doi-asserted-by":"publisher","first-page":"e202302312","DOI":"10.26508\/lsa.202302312","volume":"6","author":"M Tomaz da Silva","year":"2023","unstructured":"Tomaz da Silva, M. et al. Fn14 promotes myoblast fusion during regenerative myogenesis. Life Sci. Alliance 6, e202302312 (2023).","journal-title":"Life Sci. Alliance"},{"key":"10184_CR71","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/bioinformatics\/btab806","volume":"38","author":"Z Gu","year":"2022","unstructured":"Gu, Z. & Hubschmann, D. Make interactive complex heatmaps in R. Bioinformatics 38, 1460\u20131462 (2022).","journal-title":"Bioinformatics"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10184-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10184-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10184-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:02:25Z","timestamp":1783645345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10184-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10184"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10184-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.11.10.687677","asserted-by":"object"}]},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"937"}}